|
Market Closed -
NYSE
01:30:02 23/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 46.17 USD | +3.31% |
|
-1.66% | +13.72% |
| 05/09 | CONMED Corporation Announces Voluntary Recall of Genesys Crossft Suture Anchor | CI |
| 30/07 | CONMED Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| Market Cap | 138.28Cr 120.85Cr 113.58Cr 103.65Cr 194.53Cr 13TCr 194.57Cr 1.36TCr 526.01Cr 6.75TCr 519.32Cr 507.93Cr 22TCr | P/E 2026 * |
11.9x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 212.43Cr 185.64Cr 174.48Cr 159.22Cr 298.83Cr 20TCr 298.89Cr 2.09TCr 808.05Cr 10TCr 797.76Cr 780.28Cr 33TCr | EV / Sales 2026 * |
1.55x | EV / Sales 2027 * | 1.41x |
| Free-Float |
95.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CNMD | Delayed | |
CBOE
| CNMD | Real-time | |
Deutsche Boerse AG
| EC8 | Delayed | |
Tradegate
| EC8 | Real-time | |
Börse Stuttgart
| EC8 | Delayed | |
Boerse Muenchen
| EC8 | Real-time | |
Berne S.E.
| EC8 | End-of-day quote |
Last Transcript: CONMED Corporation
| 1 day | +3.31% | ||
| 1 week | -1.66% | ||
| Current month | -7.38% | ||
| 1 month | -9.59% | ||
| 3 months | +41.89% | ||
| 6 months | +28.46% | ||
| Current year | +13.72% |
| 1 week | 44.39 | 47.31 | |
| 1 month | 44.39 | 52.51 | |
| Current year | 31.44 | 53.66 | |
| 1 year | 31.44 | 53.66 | |
| 3 years | 31.44 | 117.27 | |
| 5 years | 31.44 | 159.11 | |
| 10 years | 31.44 | 159.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Beyer
CEO | Chief Executive Officer | 60 | 01/01/2025 |
John Gallagher
DFI | Director of Finance/CFO | 53 | 15/07/2026 |
Brent Lalomia
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Farkas
BRD | Director/Board Member | 74 | 23/07/2014 |
Patrick Beyer
BRD | Director/Board Member | 60 | 01/01/2025 |
David Bronson
BRD | Director/Board Member | 72 | 01/07/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/26 | Exercice | Director | 1,000 | 0.0033% | ||
| 15/07/26 | Other | Chief Financial Officer | 0 | 0% | ||
| 15/07/26 | Free | Chief Financial Officer | 92,465 | 0.3071% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.31% | -1.66% | -7.66% | -54.35% | 138.28Cr | ||
| +0.69% | +1.63% | -24.10% | +5.64% | 18TCr | ||
| -1.07% | -3.18% | -4.07% | +13.08% | 12TCr | ||
| -0.65% | -2.74% | +8.88% | +69.09% | 6TCr | ||
| +1.27% | -1.57% | -1.90% | -31.00% | 4.98TCr | ||
| -0.22% | +1.23% | +7.80% | +45.79% | 4.8TCr | ||
| +0.40% | +3.56% | +28.80% | +2.32% | 3.38TCr | ||
| +7.73% | +7.23% | - | - | 3.02TCr | ||
| +2.57% | +1.67% | +47.13% | -0.38% | 2.61TCr | ||
| -0.10% | +6.34% | +10.15% | -9.08% | 2.3TCr | ||
| Average | +1.36% | +1.34% | +7.22% | +4.57% | 5.68TCr | |
| Weighted average by Cap. | +0.82% | +0.43% | -2.90% | +13.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 136.65Cr 119.42Cr 112.24Cr 102.43Cr 192.24Cr 13TCr 192.27Cr 1.35TCr 519.81Cr 6.67TCr 513.19Cr 501.94Cr 22TCr | 143.37Cr 125.29Cr 117.75Cr 107.46Cr 201.68Cr 14TCr 201.72Cr 1.41TCr 545.34Cr 7TCr 538.4Cr 526.6Cr 23TCr |
| Net income | 12Cr 10Cr 9.59Cr 8.75Cr 16Cr 1.12TCr 16Cr 115.04Cr 44Cr 569.72Cr 44Cr 43Cr 1.84TCr | 13Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 133.06Cr 51Cr 658.99Cr 51Cr 50Cr 2.12TCr |
| Net Debt | 74Cr 65Cr 61Cr 56Cr 104.3Cr 7.09TCr 104.32Cr 730.91Cr 282.04Cr 3.62TCr 278.45Cr 272.35Cr 12TCr | 64Cr 56Cr 52Cr 48Cr 90Cr 6.1TCr 90Cr 628.85Cr 242.66Cr 3.11TCr 239.57Cr 234.32Cr 10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | $46.17 | +3.31% | 4,41,782 |
| 21/26/21 | $44.69 | -1.61% | 3,54,663 |
| 18/26/18 | $45.42 | -1.54% | 7,80,480 |
| 17/26/17 | $46.13 | -1.93% | 3,07,095 |
| 16/26/16 | $47.04 | +0.19% | 2,96,754 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CNMD Stock
Select your edition
All financial news and data tailored to specific country editions

















